Therapeutic potential of NMDA antagonists in neurodegenerative diseases
- 30 April 1994
- journal article
- research article
- Published by Elsevier in Neurobiology of Aging
- Vol. 15 (2) , 271-273
- https://doi.org/10.1016/0197-4580(94)90131-7
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- The dose-response relationship and therapeutic window for dizocilpine (MK-801) in a rat focal ischemia modelEuropean Journal of Pharmacology, 1992
- Heteromeric NMDA Receptors: Molecular and Functional Distinction of SubtypesScience, 1992
- Alternative excitotoxic hypothesesNeurology, 1992
- Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?Annals of Neurology, 1992
- Molecular cloning and characterization of the rat NMDA receptorNature, 1991
- Chronic quinolinic acid lesions in rats closely resemble Huntington's diseaseJournal of Neuroscience, 1991
- Cerebral hypoxia: some new approaches and unanswered questionsJournal of Neuroscience, 1990
- N-methyl-D-aspartate receptors and Alzheimer's diseaseNeurobiology of Aging, 1989
- N‐methyl‐D‐aspartate antagonists: Ready for clinical trial in brain ischemia?Annals of Neurology, 1989
- Brain Lesions, Obesity, and Other Disturbances in Mice Treated with Monosodium GlutamateScience, 1969